Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 295

1.

miR-675 mediates downregulation of Twist1 and Rb in AFP-secreting hepatocellular carcinoma.

Hernandez JM, Elahi A, Clark CW, Wang J, Humphries LA, Centeno B, Bloom G, Fuchs BC, Yeatman T, Shibata D.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S625-35. doi: 10.1245/s10434-013-3106-3. Epub 2013 Jul 18.

PMID:
23864307
2.

Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.

Yamada S, Okumura N, Wei L, Fuchs BC, Fujii T, Sugimoto H, Nomoto S, Takeda S, Tanabe KK, Kodera Y.

Ann Surg Oncol. 2014 Nov;21(12):3882-90. doi: 10.1245/s10434-014-3779-2. Epub 2014 May 15.

PMID:
24833103
3.

miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.

Liu AM, Xu Z, Shek FH, Wong KF, Lee NP, Poon RT, Chen J, Luk JM.

PLoS One. 2014 Jan 23;9(1):e86872. doi: 10.1371/journal.pone.0086872. eCollection 2014.

4.

Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.

Hung TM, Ho CM, Liu YC, Lee JL, Liao YR, Wu YM, Ho MC, Chen CH, Lai HS, Lee PH.

PLoS One. 2014 Feb 20;9(2):e89446. doi: 10.1371/journal.pone.0089446. eCollection 2014.

5.

MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers.

Hung CS, Liu HH, Liu JJ, Yeh CT, Chang TC, Wu CH, Ho YS, Wei PL, Chang YJ.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S360-8. doi: 10.1245/s10434-012-2482-4. Epub 2012 Aug 7.

PMID:
22868917
6.

Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells.

Dang YW, Zeng J, He RQ, Rong MH, Luo DZ, Chen G.

Asian Pac J Cancer Prev. 2014;15(12):4969-76.

7.

MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.

Dong P, Kaneuchi M, Watari H, Sudo S, Sakuragi N.

Mol Carcinog. 2014 May;53(5):349-59. doi: 10.1002/mc.21983. Epub 2013 Sep 3.

PMID:
24002805
8.

microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression.

Heo MJ, Kim YM, Koo JH, Yang YM, An J, Lee SK, Lee SJ, Kim KM, Park JW, Kim SG.

Oncotarget. 2014 May 15;5(9):2792-806.

9.

Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.

Zhang Y, Takahashi S, Tasaka A, Yoshima T, Ochi H, Chayama K.

J Gastroenterol Hepatol. 2013 Mar;28(3):565-75. doi: 10.1111/j.1440-1746.2012.07271.x.

PMID:
22989374
10.

Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.

Lee KW, Kim JH, Han S, Sung CO, Do IG, Ko YH, Um SH, Kim SH.

Ann Surg Oncol. 2012 Jan;19(1):326-35. doi: 10.1245/s10434-011-1867-0. Epub 2011 Jul 6.

PMID:
21732143
11.

Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma.

Xie Y, Wei RR, Huang GL, Zhang MY, Yuan YF, Wang HY.

Med Oncol. 2014 Mar;31(3):844. doi: 10.1007/s12032-014-0844-4. Epub 2014 Jan 25.

PMID:
24464213
12.

Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.

Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC.

J Cell Mol Med. 2011 Mar;15(3):691-700. doi: 10.1111/j.1582-4934.2010.01052.x.

14.

Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.

Yeh TS, Wang F, Chen TC, Yeh CN, Yu MC, Jan YY, Chen MF.

Ann Surg. 2014 Feb;259(2):346-54. doi: 10.1097/SLA.0000000000000223.

PMID:
24135722
15.

miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.

Li HP, Zeng XC, Zhang B, Long JT, Zhou B, Tan GS, Zeng WX, Chen W, Yang JY.

Carcinogenesis. 2013 Nov;34(11):2443-51. doi: 10.1093/carcin/bgt206. Epub 2013 Jun 5.

16.

Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma.

Wang YC, Chen YL, Yuan RH, Pan HW, Yang WC, Hsu HC, Jeng YM.

Carcinogenesis. 2010 Sep;31(9):1516-22. doi: 10.1093/carcin/bgq107. Epub 2010 Jun 4.

17.

MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.

Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.

Oncotarget. 2015 Jul 30;6(21):18613-30.

18.

MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.

Xiao F, Zhang W, Chen L, Chen F, Xie H, Xing C, Yu X, Ding S, Chen K, Guo H, Cheng J, Zheng S, Zhou L.

J Transl Med. 2013 Aug 22;11:195. doi: 10.1186/1479-5876-11-195.

19.

The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.

Chen YL, Uen YH, Li CF, Horng KC, Chen LR, Wu WR, Tseng HY, Huang HY, Wu LC, Shiue YL.

Ann Surg Oncol. 2013 Nov;20(12):4041-54. doi: 10.1245/s10434-012-2519-8. Epub 2012 Aug 22.

PMID:
22911364
20.

miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.

Li LZ, Zhang CZ, Liu LL, Yi C, Lu SX, Zhou X, Zhang ZJ, Peng YH, Yang YZ, Yun JP.

Carcinogenesis. 2014 Feb;35(2):469-78. doi: 10.1093/carcin/bgt330. Epub 2013 Oct 1.

Items per page

Supplemental Content

Write to the Help Desk